
Jonathan, a giant tortoise believed to be 194 years old, may be helping scientists understand why some animals remain healthy long after most members of their species have aged.
Researchers studying the celebrated tortoise found that sections of his genome involved in mitochondrial energy production appear to have retained an unusually orderly pattern of gene regulation.
The finding, reported in Science Advances recently, offers a possible explanation for Jonathan’s exceptional longevity. It may also point towards future ways of protecting human cells from age-related decline.
The study does not reveal a single “longevity gene”. Instead, it highlights a form of biological stability. As organisms grow older, the systems that control gene activity can become increasingly disordered. This gradual loss of precision may affect vital cellular functions, including the production of energy.
Jonathan’s genetic regulatory patterns appeared different. In key regions, the researchers detected low methylation entropy. In simple terms, the chemical signals controlling certain genes remained comparatively organised, even after almost two centuries of life.
That apparent order was especially evident in promoters. These are stretches of DNA that act as control panels for genes, helping determine when genes are active, when they are silent, and how strongly they are expressed. The promoters examined in Jonathan were linked to mitochondrial activity and RNA processing.
Mitochondria are often described as the power stations of cells. They convert nutrients into energy needed for movement, repair, communication and other biological processes. Their performance commonly deteriorates with age. This mitochondrial dysfunction is regarded as one of the central features of biological ageing.
The new findings suggest that Jonathan may have preserved unusually reliable control over genes supporting mitochondrial function. That could have helped his cells maintain a more dependable energy supply, reducing some of the damage normally associated with ageing.
The researchers caution that the result is an important clue, not proof of a complete explanation. The analysis was based on a small tissue sample collected from inside Jonathan’s cheek. Further studies will be required, particularly those using blood samples and comparisons with other tortoises, other long-lived animals and younger members of the same species.
Jonathan was reportedly hatched around 1832 in the Seychelles. He was transported to St Helena in 1882, when the island was already a British overseas territory. Today, he lives on the grounds of Plantation House, the official residence of the governor of St Helena.
The tortoise weighs approximately 204 kilograms. He has cataracts and is blind, yet his hearing remains good. Over the decades, Jonathan has become a living symbol of the island. He has also attracted visitors from around the world, including members of the British royal family.
His age makes him an unusual subject for genomic research. Scientists have examined ageing in many species, including mice, worms, flies and humans. Far fewer studies have investigated the epigenetic patterns of an animal that has survived for nearly two centuries.
Epigenetics refers to chemical modifications that influence gene activity without changing the underlying DNA sequence. One of the best-known mechanisms involves methyl groups. These small chemical structures can attach to DNA and alter whether particular genes are switched on or off.
The pattern is not static. It changes throughout life. Some changes are part of normal development. Others are associated with disease, environmental exposure or ageing. Over time, the signals can become less coordinated. Researchers describe this loss of regulatory order as increasing entropy.
Entropy is a concept borrowed from physics. In biology, it can be used to describe a drift towards disorder in complex systems. A high level of methylation entropy suggests that the chemical instructions controlling gene activity have become more variable or less predictable.
Jonathan’s pattern was notable because the promoters associated with energy production showed relatively low entropy. The implication is that their regulatory signals remained more stable than expected for such an old animal.
The study’s findings build on previous work involving exceptionally long-lived humans. A 2025 investigation of a 117-year-old woman reported unusually efficient mitochondrial function. Together, the studies raise the possibility that preserving mitochondrial performance may be a recurring feature of extreme longevity.
That possibility has practical importance. Healthy life expectancy, often called healthspan, is not the same as simply living longer. A person may survive for many years while experiencing frailty, neurological disease, loss of mobility or other chronic conditions. Longevity research increasingly focuses on extending the period of life spent in good health.
The work also connects with a wider debate about whether ageing can be treated as a modifiable biological process. Animal studies have suggested that certain medicines may delay aspects of ageing. One frequently studied drug is rapamycin, which was originally developed to prevent rejection after organ transplantation.
Rapamycin is now being investigated for its potential effects on ageing-related pathways. Other compounds are also being examined. Yet large clinical trials can be difficult to organise, particularly when a medicine is no longer protected by a patent.
Commercial drug companies may have limited financial motivation to fund such trials. The medicine may be inexpensive, competition may be strong, and any resulting treatment could be difficult to commercialise. Non-profit organisations hope to address that gap by supporting research that does not fit conventional commercial priorities.
A longevity-focused foundation involved in the tortoise study has said that it aims to conduct clinical trials of promising generic medicines. Those trials would require substantial funding, careful design and regulatory approval. They would also need to distinguish genuine effects on healthy ageing from temporary improvements or reductions in disease risk.
The interest in Jonathan began with a separate medical question. Researchers had noticed that the incidence of certain brain and central nervous system tumours rises through later adulthood, then appears to level off or decline among the oldest people.
Some cancers, including neuroblastoma, are rarely diagnosed in people in their nineties. This pattern prompted a question: might people who reach extreme old age possess biological features that protect them from some forms of cancer?
Modern sequencing technology has made it possible to explore such questions in much greater detail. Next-generation sequencing can examine large portions of the genome rapidly. It can also identify epigenetic marks, including methylation patterns, across selected areas of DNA.
In Jonathan’s case, obtaining biological material was not straightforward. A blood sample was considered unsuitable because of concerns about the animal’s health. A small cheek-tissue sample was collected instead.
The researchers described the resulting gene activity as high fidelity. This does not mean that Jonathan’s genome remained unchanged. Mutations and other molecular changes accumulate during life. Rather, the finding suggests that some of the chemical instructions controlling gene expression retained a high degree of consistency.
That distinction matters. Ageing is not caused by one process alone. It involves changes to DNA, proteins, immune function, metabolism, tissue repair and cellular communication. Mitochondrial dysfunction is one part of a much larger network.
The study also cannot establish whether Jonathan’s orderly methylation patterns caused his long life or resulted from it. He may have survived because of these biological characteristics. Alternatively, long life in his species may naturally preserve certain epigenetic patterns. It is also possible that several explanations are operating together.
The next phase of research will require broader comparisons. Scientists could examine blood or tissue from other giant tortoises of different ages. They could compare Jonathan with tortoises that lived shorter lives. They might also investigate whales, elephants, certain bats and other species known for unusual longevity.
Such work could reveal whether low methylation entropy is a general marker of healthy ageing or a feature specific to Jonathan. It could also identify other biological pathways that remain unusually stable in long-lived animals.
Human applications remain distant. A tortoise and a human differ substantially in physiology, metabolism and life history. Findings from one species cannot be transferred directly into a treatment. Any medicine designed to influence methylation, mitochondrial activity or gene expression would require extensive safety testing.
Jonathan continues to live at Plantation House, where his daily routine is considerably quieter than the scientific interest surrounding him. His story, however, has already expanded beyond a record of age. It has become a case study in how nature may protect biological systems from the disorder that usually accompanies time.
The post This 194-Year-Old Giant Tortoise May Hold the Secret to a Longer, Healthier Life, New Research Finds first appeared on PP Health Malaysia (PPHM) | 10POINTS Evidence-Based Health News.


